Leading the way to safer medication
 Crosscheck  Recommender

Atazanavir

Description

Atazanavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag-Pol proteins in HIV-1 infected cells, thus preventing formation of mature virions and infection of other cells.

ATC Classification

Code
Title
Category
J05AE08
Atazanavir
J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors

Trade names

Trade name
Countries

Australia Austria Canada Cyprus France

Trade names (in combination): EVOTAZ

Product Monographs

Monograph
Type
Country
REYATAZ Hard capsules
MPI, EU: SmPC